Omnicell Guides Q3 Revenue to $301M-$307M, Setting the Bar for the Quarter
OMCL sits 45% above its 52-week low of $28.514 on elevated volume (1.9× avg).
Summary
Omnicell issued Q3 revenue guidance of $301M-$307M, a first look at the upcoming quarter's top-line expectations. The company also provided adjusted EPS guidance of $0.35 to $0.43. This follows a strong Q1 turnaround to GAAP profitability and a recent leadership appointment of Nnamdi Njoku as President. The guidance provides a concrete benchmark for the company's continued recovery trajectory. With the stock at $41.40 and a market cap near $1.9B, the range will be closely measured against consensus estimates when they become available.
At the time of this announcement, OMCL was trading at $41.40 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $28.51 to $55.00. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.